Article Type
Review
Published
This multicentre, retrospective study evaluates the efficacy and safety of risankizumab in a population of psoriatic patients with palmoplantar involvement over a 52-week treatment period.
Tag: psoriasis
Article Type
Original Research
Published
This study characterizes the sensorial attributes of the calcipotriol
(CAL) and betamethasone dipropionate (BDP) polyaphron dispersion cream vehicle and compares them with the sensorial attributes of conventional formulations for psoriasis such as an ointment and an oleogel product.
Article Type
Case Report
Published
This article describes four case studies of proactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psoriasis for up to 12 months from initial presentation.
Article Type
Review
Published
the focus of this article is to review the current evidence on how epidemiology, clinical presentation and genetic differences in patients with skin of colour with psoriasis may impact treatment strategies.
Article Type
Editorial
Published
Bimekizumab is mentioned in the recent report by Clarivate, Drugs to Watch in 2021, as one of the drugs to be observed in 2021. This article discusses the current status of bimekizumab.